Philip Lyng Madsen: Re-thinking how patients can contribute to research

Send us Fan MailAfter a successful career as a strategy consultant, Philip is attracted by the higher purpose of the life sciences space and takes on a quest to find solutions for why clinical trial timelines are growing longer and more complex. Even though his project is still in stealth mode, Philip takes Sam and Ivanna through some of the reasons he has uncovered so far.We speak about the apprehension in the industry of trying new things, and how different roles in clinical trials perceive some of the same problems from different angles. We dive into recruitment of patients for clinical trials and how patient empowerment is changing how we engage with the health system. We imagine a fusion of research and treatment where trial treatment could be integrated into the treatment options patients are met with in the primary care - or even consider an opt-out model for contributing data for science. "Everyone with a condition should be able to contribute to finding a cure"- Philip Lyng MadsenNotes:Guest Philip Lyng Madsen: https://www.linkedin.com/in/philiplyng/ Medicon Valley Alliance: https://mva.org/ Abbreviations: CRO: Clinical Research Organization IRB: Institutional Review BoardPI: Principal Investigator POC: Proof of ConceptVisit Labtolives.com Do you want to try the quiz from this episode? Find the link on our LinkedIn profile: https://www.linkedin.com/company/labtolives/ Would you like to join the show as a guest or collaborator? Find out how on our website: https://www.labtolives.com/ Support the show________Reach out to Ivanna RosendalJoin the conversation on our LinkedIn pageVisit www.labtolives.com HostsAlexander Booth aka the MedTech GuyDimitri Borisevich aka the start-up GuyIvanna Rosendal aka the R&D pharma Gal